YU402A - New 2,3-benzodiazepine derivatives - Google Patents
New 2,3-benzodiazepine derivativesInfo
- Publication number
- YU402A YU402A YU402A YUP402A YU402A YU 402 A YU402 A YU 402A YU 402 A YU402 A YU 402A YU P402 A YUP402 A YU P402A YU 402 A YU402 A YU 402A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- bond
- positions
- hydrogen
- lower alkyl
- present
- Prior art date
Links
- RPBDCDQMCRHNLM-UHFFFAOYSA-N C1=NNC=C2C=CC=CC2=C1 Chemical class C1=NNC=C2C=CC=CC2=C1 RPBDCDQMCRHNLM-UHFFFAOYSA-N 0.000 title abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The invention relates to new 2,3-benzodiazepine derivatives of general Formula (I), (wherein R1 stands for methyl, formyl, carboxy, cyano, -CH=NOH, -CH=NNHCONH2 or -NR5R6, wherein R5 and R6 independently from each other represent hydrogen or lower alkyl or together with the nitrogen atom, they are attached to, form a 5- or 6-membered, saturated or unsaturated heterocyclic ring optionally containing one or more further nitrogen, sulfur and/or oxygen atom(s); R2 is nitro or amino; R3 stands for hydrogen, lower alkanoyl or CO-NR7R8, wherein R7 and R8 independently from each other stand for hydrogen, lower alkoxy, lower alkyl or lower cycloalkyl or together with the nitrogen atom, they are attached to, form a 5- or 6-membered, saturated or unsaturated heterocyclic ring optionally containing one or more further nitrogen, sulfur and/or oxygen atom(s); R4 is hydrogen or lower alkyl; the dotted lines have the following meaning: if R3 and R4 are not present, the bond between positions C8 and C9 is a single bond and the bond between positions C8 and N7 is a double bond; if R3 and R4 are present, the bonds between positions C8 and C9 and between position C8 and N7 are single bonds; and if R3 is present and R4 is missing, the bond between positions C8 and C9 is a double bond and the bond between positions C8 and N7 is a single bond) and salts thereof. The invention compounds have neuroprotective effect.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902291A HU227128B1 (en) | 1999-07-07 | 1999-07-07 | New 2,3-benzodiazepine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU402A true YU402A (en) | 2004-11-25 |
Family
ID=89998666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU402A YU402A (en) | 1999-07-07 | 2000-07-04 | New 2,3-benzodiazepine derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7053082B1 (en) |
| EP (1) | EP1200442B8 (en) |
| JP (1) | JP2003504372A (en) |
| KR (1) | KR100818001B1 (en) |
| CN (1) | CN1162432C (en) |
| AT (1) | ATE243699T1 (en) |
| AU (1) | AU5836300A (en) |
| BG (1) | BG65405B1 (en) |
| CA (1) | CA2378305A1 (en) |
| CZ (1) | CZ20014698A3 (en) |
| DE (1) | DE60003561T2 (en) |
| DK (1) | DK1200442T3 (en) |
| HK (1) | HK1047581B (en) |
| HR (1) | HRP20020015B1 (en) |
| HU (1) | HU227128B1 (en) |
| PL (1) | PL351839A1 (en) |
| RO (1) | RO121853B1 (en) |
| RU (1) | RU2243228C2 (en) |
| SK (1) | SK286680B6 (en) |
| UA (1) | UA72261C2 (en) |
| WO (1) | WO2001004122A2 (en) |
| YU (1) | YU402A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU225100B1 (en) | 2000-12-21 | 2006-06-28 | Egyt Gyogyszervegyeszeti Gyar | 2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and their use |
| US6858605B2 (en) | 2003-02-04 | 2005-02-22 | Ivax Drug Research Institute, Ltd. | Substituted 2,3-benzodiazepine derivatives |
| CA2633804A1 (en) * | 2005-12-30 | 2007-07-12 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| FR2972454B1 (en) * | 2011-03-08 | 2013-03-01 | Servier Lab | NOVEL DIHYDRO-OXAZOLOBENZODIAZEPINONES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179018B (en) * | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
| HU191702B (en) * | 1984-06-27 | 1987-03-30 | Gyogyszerkutato Intezet | New process for preparing 1-aryl-5 h-2,3-benzodiazepines |
| HU191698B (en) * | 1984-07-27 | 1987-03-30 | Gyogyszerkutato Intezet | Process for producing new 1-aryl-5h-2beta-benzodiazepines |
| HU195788B (en) * | 1986-05-21 | 1988-07-28 | Gyogyszerkutato Intezet | Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them |
| HU219778B (en) * | 1990-12-21 | 2001-07-30 | Gyógyszerkutató Intézet Közös Vállalat | Process for producing n-acyl-2,3-benzodiazepine derivatives, their acid additional salts and pharmaceutical compositions containing them and a grop of the compounds and pharmaceutical compositions containing them |
| HU206719B (en) * | 1990-12-21 | 1992-12-28 | Gyogyszerkutato Intezet | Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them |
| HU219777B (en) * | 1993-07-02 | 2001-07-30 | Gyógyszerkutató Intézet Kft. | Optical active 1-(4-nitrophenyl)-4-methyl-7,8-methylen dioxi-3,4-dihydro-5h-2,3-benzodiazepine and process for producing it |
| DE4428835A1 (en) * | 1994-08-01 | 1996-02-08 | Schering Ag | New 3-substituted 3H-2,3-benzodiazepine derivatives, their production and use as medicines |
| DK0771198T3 (en) * | 1994-08-31 | 2002-04-22 | Lilly Co Eli | Dihydro-2,3-benzodiazepine |
| US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| UA67749C2 (en) * | 1997-08-12 | 2004-07-15 | Егіш Дьйодьсердьяр Рт. | 8-substituted-9h-1,3-dioxolo-[4,5-h][2,3]benzodiazepine being inhibitors of the ampa/kainite receptor |
-
1999
- 1999-07-07 HU HU9902291A patent/HU227128B1/en not_active IP Right Cessation
-
2000
- 2000-04-07 UA UA2002020975A patent/UA72261C2/en unknown
- 2000-07-04 KR KR1020027000200A patent/KR100818001B1/en not_active IP Right Cessation
- 2000-07-04 PL PL00351839A patent/PL351839A1/en not_active Application Discontinuation
- 2000-07-04 DE DE60003561T patent/DE60003561T2/en not_active Expired - Lifetime
- 2000-07-04 SK SK17-2002A patent/SK286680B6/en not_active IP Right Cessation
- 2000-07-04 AU AU58363/00A patent/AU5836300A/en not_active Abandoned
- 2000-07-04 CN CNB008100152A patent/CN1162432C/en not_active Expired - Fee Related
- 2000-07-04 AT AT00944129T patent/ATE243699T1/en not_active IP Right Cessation
- 2000-07-04 YU YU402A patent/YU402A/en unknown
- 2000-07-04 CZ CZ20014698A patent/CZ20014698A3/en unknown
- 2000-07-04 CA CA002378305A patent/CA2378305A1/en not_active Abandoned
- 2000-07-04 WO PCT/HU2000/000074 patent/WO2001004122A2/en active IP Right Grant
- 2000-07-04 JP JP2001509731A patent/JP2003504372A/en active Pending
- 2000-07-04 RO ROA200200003A patent/RO121853B1/en unknown
- 2000-07-04 DK DK00944129T patent/DK1200442T3/en active
- 2000-07-04 EP EP00944129A patent/EP1200442B8/en not_active Expired - Lifetime
- 2000-07-04 RU RU2002103311/04A patent/RU2243228C2/en not_active IP Right Cessation
- 2000-07-04 US US10/030,436 patent/US7053082B1/en not_active Expired - Fee Related
-
2002
- 2002-01-07 HR HR20020015A patent/HRP20020015B1/en not_active IP Right Cessation
- 2002-01-07 BG BG106281A patent/BG65405B1/en unknown
- 2002-10-18 HK HK02107601.4A patent/HK1047581B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7053082B1 (en) | 2006-05-30 |
| CZ20014698A3 (en) | 2002-06-12 |
| RU2243228C2 (en) | 2004-12-27 |
| HK1047581A1 (en) | 2003-02-28 |
| RO121853B1 (en) | 2008-06-30 |
| DE60003561D1 (en) | 2003-07-31 |
| DK1200442T3 (en) | 2003-10-20 |
| PL351839A1 (en) | 2003-06-16 |
| CN1370174A (en) | 2002-09-18 |
| JP2003504372A (en) | 2003-02-04 |
| EP1200442A1 (en) | 2002-05-02 |
| AU5836300A (en) | 2001-01-30 |
| CN1162432C (en) | 2004-08-18 |
| SK286680B6 (en) | 2009-03-05 |
| CA2378305A1 (en) | 2001-01-18 |
| EP1200442B8 (en) | 2003-08-20 |
| KR20020022765A (en) | 2002-03-27 |
| WO2001004122A2 (en) | 2001-01-18 |
| HU227128B1 (en) | 2010-07-28 |
| WO2001004122A3 (en) | 2001-05-10 |
| KR100818001B1 (en) | 2008-03-31 |
| UA72261C2 (en) | 2005-02-15 |
| HRP20020015B1 (en) | 2005-02-28 |
| HK1047581B (en) | 2004-04-30 |
| ATE243699T1 (en) | 2003-07-15 |
| HRP20020015A2 (en) | 2004-08-31 |
| HUP9902291A2 (en) | 2001-12-28 |
| DE60003561T2 (en) | 2004-04-29 |
| EP1200442B1 (en) | 2003-06-25 |
| BG106281A (en) | 2003-01-31 |
| HU9902291D0 (en) | 1999-09-28 |
| SK172002A3 (en) | 2002-06-04 |
| BG65405B1 (en) | 2008-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1074542A4 (en) | Sulfonamide-containing indole compounds | |
| CA2316902A1 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
| TW341565B (en) | Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them | |
| NZ330973A (en) | Azolobenzazepine derivatives as neurologically active agents | |
| NZ514662A (en) | Amine derivatives | |
| ES2048109A1 (en) | New piperidine derivatives of benzimidazole as antihistanminic and antiallergic agents. | |
| AU2267495A (en) | Benzamide derivatives as vasopressin antagonists | |
| BG104069A (en) | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor | |
| MX9806171A (en) | 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors. | |
| AU626980B2 (en) | Tetrahydrobenzimidazole derivatives | |
| HUP0004477A2 (en) | Herbicidal 3(-1,2-benzisothiazol or isoxazol-5 yl)-substituted pyrimidine derivatives, intermediates, preparation and use thereof | |
| HUP0203645A2 (en) | Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use | |
| WO2002000638A3 (en) | Substituted phthalides as anti-convulsive drugs | |
| YU402A (en) | New 2,3-benzodiazepine derivatives | |
| MY131762A (en) | Pharmaceutical compounds | |
| IL132799A0 (en) | 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis | |
| UA41880C2 (en) | Serotoninergic derivatives of ergolin and a pharmaceutical composition | |
| AU686934B2 (en) | 2-heterocyclicethylamine derivatives and their use as pharmaceuticals | |
| AU2002214320A1 (en) | Imidazole derivatives, process for their preparation and their use | |
| AU3285000A (en) | 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis | |
| TW340844B (en) | Amide derivatives | |
| ATE216368T1 (en) | HETEROCYCLIC CARBOXYALKYL DERIVATIVES | |
| AU3648093A (en) | Pyrrolidine derivatives useful as 5-HT3-antagonists | |
| HU9602534D0 (en) | Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity | |
| ES2012567A6 (en) | Condensed quinolinium and isoquinolinium derivatives |